Allogeneic cell therapy for patients who relapse after autologous stem cell transplantation.

• 1 April 2001
• journal article
• clinical trial
• Published by Elsevier in Transplantation and Cellular Therapy
• Vol. 7  (4) , 230-238
• https://doi.org/10.1053/bbmt.2001.v7.pm11349810

Abstract

Keywords

• TOXICITY
• PROPHYLAXIS
• MIXED CHIMERISM
• SCT
• ALLOGENEIC CELL THERAPY
• PRIOR
• DONOR LEUKOCYTE
• GVT ACTIVITY